财联社11月28日讯（记者 张良德） 2024年国家医保目录今日正式公布，91种药品新进入国家医保药品 目录，平均降价63%，本次新增11种中成药，其中10种均为去年及今年获批上市的新药。 中药领域知名营销专家、赛柏兰高级顾问孙跃武对财联社记者表示，越来越多的产品进到医保目录，说 明企业对国家政策认同，同时此次医保降价幅度略低于市场此前预期，说明政策也充分考虑到了企业经 营成本等各个方面因素。 在这次纳入新版医保目录的11种新药中，创新药的属性明显偏高，其中中药1.1类新药5种、中药3.1类新 药3种，另有1.2类新药1种，2.2类改良剂型新药1种，且该药品为儿科用药。 | --- | --- | |-------------------------------------------------------------------------------------------|---------------------------------------| | | | | 财联社记者梳理资料发现，上述 11 种中成药共涉及华润三九（ 000999.SZ | ）、健民集团（ 600976.SH ）、 | | ...

证券时报e公司讯，康隆达(603665)11月28日晚间公告，公司拟将控股子公司美国GGS转让给Globus或其 新设立的子公司，交易对价为美国GGS公司价值金额6100万美元按照股权购买协议约定的调整机制进行 调整后的金额。 交易完成后，公司将不再持有美国GGS股权。 此次交易将有利于优化资产结构，集中优势资源，提高资产运营效率。 ...

BP plc’s (BP) subsidiary BP Trinidad and Tobago (“BPTT”) is making significant strides toward achieving its goal of first gas from the Cypre subsea gas development project by 2025. Located off the southeast coast of Trinidad and Tobago, the project represents BPTT’s third subsea development in the region and is poised to enhance the country’s natural gas production capacity.After securing the final investment decision in 2022, BP collaborated with Subsea Integration Alliance and Aquaterra Energy to advance ...

文章核心观点 - Cheniere Energy获得联邦能源管理委员会（FERC）批准，推进其在德克萨斯州Corpus Christi的第三阶段液化天然气（LNG）扩建项目，预计将于2024年底开始生产LNG，增加1000万吨/年的产能，以满足全球对清洁能源日益增长的需求 [1][2][5] 项目详情 - Corpus Christi第三阶段项目涉及建设七个新的天然气处理单元，完成后将增加约1000万吨/年的LNG生产能力 [2] 行业角色 - 天然气作为清洁能源替代品，在全球能源转型中扮演重要角色，Cheniere的扩张有助于支持全球向清洁能源的过渡 [3] 公司运营 - Cheniere在美国拥有并运营两个主要LNG终端，分别位于路易斯安那州的Sabine Pass和德克萨斯州的Corpus Christi，并通过管道供应天然气 [4] 市场表现 - Cheniere Energy目前持有Zacks Rank 3（持有），投资者可关注其他能源领域排名更高的公司，如Petrofac Limited（POFCY）、Targa Resources Corp.（TRGP）和TechnipFMC plc（FTI），均持有Zacks Rank 2（买入） [6] - Petrofac估值为6787万美元，业务涵盖陆上工程与建设、海上项目与运营、工程咨询服务和综合能源服务 [7] - Targa Resources估值为443.6亿美元，过去一年股价上涨130.2%，提供天然气和天然气液体的收集、处理、运输、储存和营销服务 [8] - TechnipFMC估值为132亿美元，每年支付每股20美分的股息，为能源行业提供产品、服务和集成技术解决方案 [9]

HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Metalpha Technology Holding Limited (Nasdaq: MATH) (the "Company" or "Metalpha"), a global digital asset-focused wealth management company, today announced the appointment of Mr. Pengyuan Fan as Chief Financial Officer of the Company ("CFO"), effective on November 28, 2024.Mr. Pengyuan Fan brings over 15 years' experience of key positions at a leading high-frequency trading firm, Royal Bank of Scotland and UBS in London. Mr. Fan graduated with both Bachelor of Arts ( ...

NEW YORK, Nov. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Zeta Global Holdings Corp. (NYSE: ZETA) between February 27, 2024 and November 13, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 21, 2025. SO WHAT: If you purchased Zeta securities during ...

JR Research is an opportunistic investor. He was recognized by TipRanks as a Top Analyst. He was also recognized by Seeking Alpha as a "Top Analyst To Follow" for Technology, Software, and Internet, as well as for Growth and GARP. He identifies attractive risk/reward opportunities supported by robust price action to potentially generate alpha well above the S&P 500. He has also demonstrated outperformance with his picks. He focuses on identifying growth investing opportunities that present the most attracti ...

Charles River Laboratories International, Inc. (CRL) continues to enhance its portfolio through targeted partnerships and acquisitions, poised to drive growth in the upcoming quarters. The company’s RMS (Research Models and Services) is witnessing broad-based growth in all geographic regions for small research models. Sound financial health also bodes well for the stock.  Meanwhile, volatilities in the biopharma industry remain a challenge for Charles River. Intense rivalry from other industry players adds ...

Michael Wiggins De Oliveira is an inflection investor. This means buying into cheap companies at the moment when their narrative is changing and the business is on a path toward becoming significantly more profitable over the next year.With a focus on tech and “the Great Energy Transition (including uranium)”, Michael runs a concentrated portfolio with approximately 15 to 20 stocks and an average holding period of 18 months. Through his 10+ years analyzing countless companies, Michael has accumulated outsta ...

Hologic, Inc. (HOLX) is set to unveil groundbreaking technologies at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, to be held from Dec. 1-5. With a focus on enhancing breast health care, the company will showcase AI-powered breast imaging advancements designed to assess breast density, enhance workflows and improve cancer detection.Additionally, in the same event, Hologic will present the results of a recently published study demonstrating t ...